Search PubMed⌕ Search

Biomedical subjects

J Camm

Publications and source records attributed to J Camm.

At least 19 recordsLinked to original sources
PubMed2006

Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events.

BACKGROUND: Atrial fibrillation (AF) is the most frequently occurring cardiac arrhythmia with often serious clinical consequences. Many patients have contraindications to anticoagulation, and it is often underused in clinical practice. The addition of clopidogrel to aspirin (ASA) has been shown to reduce vascular events in a number of high-risk populations. Irbesartan is an angiotensin receptor-blocking agent that reduces blood pressure and has other vascular protective effects. METHODS AND RESULTS: ACTIVE W is a noninferiority trial of clopidogrel plus ASA versus oral anticoagulation in patients with AF and at least 1 risk factor for stroke. ACTIVE A is a double-blind, placebo-controlled trial of clopidogrel in patients with AF and with at least 1 risk factor for stroke who receive ASA because they have a contraindication for oral anticoagulation or because they are unwilling to take an oral anticoagulant. ACTIVE I is a partial factorial, double-blind, placebo-controlled trial of irbesartan in patients participating in ACTIVE A or ACTIVE W. The primary outcomes of these studies are composites of vascular events. A total of 14000 patients will be enrolled in these trials. CONCLUSIONS: ACTIVE is the largest trial yet conducted in AF. Its results will lead to a new understanding of the role of combined antiplatelet therapy and the role of blood pressure lowering with an angiotensin II receptor blocker in patients with AF.

Aged↗
PubMed2000

Spontaneous episodes of atrial fibrillation after implantation of the Metrix Atrioverter: observations on treated and nontreated episodes. Metrix Investigators.

OBJECTIVES: We sought to evaluate the number and duration of device-treated and self-terminating, nontreated episodes of atrial fibrillation (AF) after implantation of the Metrix Atrioverter. BACKGROUND: A recent study has shown that the Atrioverter can rapidly restore sinus rhythm in patients with AF; however, the effect of the device on the clinical course of the arrhythmia in these patients is unknown. METHODS: The Atrioverter was implanted in 51 patients with symptomatic, recurrent, drug-refractory AF. The device was programmed to periodically monitor the cardiac rhythm. Defibrillation of AF episodes was performed under physician observation. RESULTS: During a mean follow-up of 260 +/- 144 days, 1,161 episodes of AF were observed during valid monitoring periods in 45 of 51 patients. Forty-one patients experienced 231 episodes for which they sought defibrillation therapy. The average duration of the treated episodes during valid monitoring periods (190 of 231 episodes in 39 of 41 patients) was significantly longer than that of the nontreated episodes (38 +/- 44 vs. 10 +/- 8 h; p < 0.05). The time between episodes requiring Atrioverter therapy increased, and the risk of having an episode requiring treatment decreased. No changes were observed in the number and duration of the short-lasting, nontreated episodes as time since implantation of the device increased. CONCLUSIONS: In patients with symptomatic, recurrent, drug-refractory AF, the frequency of long-lasting episodes, which were treated under observation with repeated defibrillation using the Atrioverter, decreased. The number and duration of short-lasting, nontreated episodes did not change during the 20-month study period. The effect of ambulatory use of the device on the recurrence of short-lasting episodes needs to be evaluated.

Adult↗
PubMed2000

The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy.

OBJECTIVES: We sought to assess the impact of intermittent atrial fibrillation (AF) on health-related quality of life (QoL). BACKGROUND: Intermittent AF is a common condition with little data on health-related QoL questionnaires to guide investigational therapies. METHODS: Outpatients from four centers, with documented AF (n = 152), completed validated QoL questionnaires (Medical Outcomes Study Short Form 36 [SF-36], Specific Activity, Symptom Checklist, Illness Intrusiveness and University of Toronto AF Severity Scales). Comparison groups were made up of healthy individuals (n = 47) and four cardiac control groups: published (n = 78) and created for study (n = 69) percutaneous transluminal coronary angioplasty (PTCA); published heart failure (n = 216) and published postmyocardial infarction (MI) (n = 107). RESULTS: Across all domains of the SF-36, AF patients reported substantially worse QoL than healthy controls (1.3 to 2.0 standard deviation units), with scores of 24%, 23%, 16% and 30% lower than healthy individuals on measures of physical and social functioning, mental and general health, respectively (all p < 0.001). Patients with AF were either significantly worse (p < 0.05, published controls) or as impaired (study controls) as either PTCA or post-MI patients on all domains of the SF-36 and the same as heart failure controls on SF-36 psychological subscales. Patients with AF were as impaired or worse than study PTCA controls on measures of illness intrusiveness, activity limitations and symptoms. Associations between objective disease indexes and subjective QoL measures had poor correlations and accounted for <6% of the total variability in QoL scores. CONCLUSIONS: Quality of life is as impaired in patients with intermittent AF as in patients with significant structural heart disease. Patients' perception of QoL is not dependent on the objective measures of disease severity that are usually employed.

Anti-Arrhythmia Agents↗
PubMed1998

Classification of atrial fibrillation.

Atrial fibrillation (AF) is the subject of several overlapping schemes of classification in which the subgroups are often poorly defined. New methods of classification have been applied to accommodate new information and new concepts. These are often appropriate only in limited circumstances and may lead to confusion if applied out of context. We will describe the principal schemes used to classify AF and discuss the limitations of each.

Atrial Fibrillation↗
PubMed1998

Species distributions, land values, and efficient conservation

Efforts at species conservation in the United States have tended to be opportunistic and uncoordinated. Recently, however, ecologists and economists have begun to develop more systematic approaches. Here, the problem of efficiently allocating scarce conservation resources in the selection of sites for biological reserves is addressed. With the use of county-level data on land prices and the incidence of endangered species, it is shown that accounting for heterogeneity in land prices results in a substantial increase in efficiency in terms of either the cost of achieving a fixed coverage of species or the coverage attained from a fixed budget.

Journal Article↗
PubMed1998

The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens.

AIMS: To evaluate the prognostic value of the QT interval and QT interval dispersion in total and in cardiovascular mortality, as well as in cardiac morbidity, in a general population. METHODS AND RESULTS: The QT interval was measured in all leads from a standard 12-lead ECG in a random sample of 1658 women and 1797 men aged 30-60 years. QT interval dispersion was calculated from the maximal difference between QT intervals in any two leads. All cause mortality over 13 years, and cardiovascular mortality as well as cardiac morbidity over 11 years, were the main outcome parameters. Subjects with a prolonged QT interval (430 ms or more) or prolonged QT interval dispersion (80 ms or more) were at higher risk of cardiovascular death and cardiac morbidity than subjects whose QT interval was less than 360 ms, or whose QT interval dispersion was less than 30 ms. Cardiovascular death relative risk ratios, adjusted for age, gender, myocardial infarct, angina pectoris, diabetes mellitus, arterial hypertension, smoking habits, serum cholesterol level, and heart rate were 2.9 for the QT interval (95% confidence interval 1.1-7.8) and 4.4 for QT interval dispersion (95% confidence interval 1.0-19-1). Fatal and non-fatal cardiac morbidity relative risk ratios were similar, at 2.7 (95% confidence interval 1.4-5.5) for the QT interval and 2.2 (95% confidence interval 1.1-4.0) for QT interval dispersion. CONCLUSION: Prolongation of the QT interval and QT interval dispersion independently affected the prognosis of cardiovascular mortality and cardiac fatal and non-fatal morbidity in a general population over 11 years.

Adult↗
PubMed1995

Examination of a resin-modified glass-ionomer material as a pit and fissure sealant.

The purpose of this in vitro study was to examine the effect of various powder-liquid ratios of an experimental resin-modified glass-ionomer polymer cement on dye penetration when the cement was used as a pit and fissure sealant. Eighty extracted human third molars were randomly assigned to one of four pit and fissure sealant conditions: a resin-based sealant or one of three variations in powder-liquid ratios (1.4:1.0, 1.8:1.0, and 2.0:1.0) of an experimental, light-activated, resin-modified glass-ionomer cement. After sealant placement, the teeth were thermocycled and immersed in methylene blue dye. The teeth were sectioned, and the extent of dye penetration along the sealant-enamel interface was measured linearly. The resin-sealed occlusal fissures showed statistically significantly less dye penetration than did the three powder-liquid ratios of the experimental resin-modified glass-ionomer-cement sealant.

Analysis of Variance↗
PubMed1994

Temporal influences on the prediction of postinfarction mortality by heart rate variability: a comparison with the left ventricular ejection fraction.

OBJECTIVE: To examine the influence of the duration of follow up on the values of heart rate variability (HRV) and the left ventricular ejection fraction (LVEF) for predicting mortality after infarction. BACKGROUND: HRV is an index of autonomic balance that identifies patients at a high risk of arrhythmic events. The index is most depressed during the first few weeks after myocardial infarction whereas left ventricular function tends to deteriorate with time. HYPOTHESIS: The value of depressed HRV measured before discharge from hospital for predicting mortality after infarction should decline with time. METHODS: The HRV and the LVEF were assessed in 433 survivors of a first acute myocardial infarction: HRV < 20 units and LVEF < 40% were taken as cut off points. Kaplan-Meier survival functions for total cardiac mortality and sudden cardiac death were calculated for the whole five year follow up period and for different intervening periods. RESULTS: During follow up of four weeks to five years there were 46 (10.6%) deaths and 15 (3.5%) patients died suddenly. Within the whole follow up period, HRV < 20 units and LVEF < 40% were both strongly associated with total cardiac mortality (p < 0.0001), but HRV was an independent predictor of total cardiac mortality only during the first six months of follow up. There were no deaths predicted by HRV < 20 units after the first year of follow up whereas LVEF < 40% had a sensitivity of 43% and a positive predictive accuracy of 9% for predicting death during this period. HRV < 20 units was better than LVEF < 40% in predicting sudden deaths during the first year of follow up but was an independent predictor only of those sudden deaths occurring within six months of infarction. CONCLUSIONS: The duration of follow up affects the prediction of sudden death and total cardiac mortality from HRV. Reduced HRV as measured before discharge from hospital does not seem to retain independent prognostic value after six months of follow up. These findings have potential implications for the serial evaluation of HRV and for the prevention of sudden death after myocardial infarction.

Death, Sudden, Cardiac↗
PubMed1993

Influence of thrombolytic therapy on the evolution of baroreflex sensitivity after myocardial infarction.

Depressed baroreceptor sensitivity (BRS) has been associated with an increased risk of ventricular arrhythmias and sudden cardiac death after myocardial infarction, but the influence of thrombolytic therapy on BRS has not been examined. To determine the effect of thrombolytic therapy on the evolution of BRS after myocardial infarction, BRS was assessed at 6 days, 6 weeks, and 3 months in 76 patients, 53 (70%) of whom had received thrombolytic therapy. The mean age (57 vs 57 years), sites of infarction, and the proportion of patients taking beta-blockers (68% vs 52%) did not differ between patients who did and those who did not receive thrombolytic therapy. There was no difference in predischarge mean left ventricular ejection fractions (42% vs 46%) between the two groups of patients, but mean baseline BRS was 9.2 (0.8) msec/mm Hg in patients who were treated with thrombolysis and 5.9 (1.3) msec/mm Hg in those who were not (p = 0.03). At 6 weeks the corresponding values were 9.7 (1.1) and 11.1 (2.8) msec/mm Hg (p = 0.6) and at 3 months 9.1 (1.0) and 6.5 (1.1) msec/mm Hg (p = 0.07). At baseline 13% of patients who were treated with thrombolysis and 13% of those who were not had BRS < 3.0 msec/mm Hg, but at 3 months 9% of patients who were treated with thrombolytic agents compared with 17% of those who had BRS < 3.0 msec/mm Hg. In conclusion, early after myocardial infarction mean BRS was higher in patients treated with thrombolysis compared with nontreated patients.(ABSTRACT TRUNCATED AT 250 WORDS)

Aging↗
PubMed1993

Autonomic correlates of late infarct artery patency after first myocardial infarction.

Occlusion of the infarct-related artery has recently been associated with an increased risk of sudden death, particularly in patients with poor left ventricular function. Depressed heart rate variability (HRV) also identifies postinfarction patients at an increased risk of sudden death. The correlation between infarct artery patency, left ventricular function, and HRV was therefore examined in 186 survivors of a first myocardial infarction. Predischarge coronary angiography and Holter monitoring were carried out in 186 patients with a first acute myocardial infarction. Coronary angiography was performed because of abnormal predischarge exercise test findings. Mean age (56 +/- 9 years) and the proportions of type and site of infarction did not differ between patients with occluded or patent arteries or between patients who did or did not undergo coronary angiography. The mean left ventricular ejection fraction (EF) was 55 +/- 15% in patients with patent and 49 +/- 14% in those with occluded infarct arteries (p < 0.001), and the EF was < 40% in 17% and 28% of the respective groups (p < 0.05). HRV was < 20 U in 7 (18%) of the 39 patients with an EF < 40% but in only 7 (5%) of the 147 patients with an EF > 40% (p < 0.02).(ABSTRACT TRUNCATED AT 250 WORDS)

Adult↗
PubMed1992

Geometrically accurate activation mapping of the atrioventricular node region during surgery.

A novel method has been developed to map activation in the triangle of Koch during surgery for cardiac arrhythmias and relate the map to anatomic landmarks. It uses a hand-held electrode mounted in a freely moving linkage that has three degrees of mechanical freedom. The movements of the linkage are sensed by a computer that continuously calculates the coordinates of the electrode. The surgeon clamps the device over the triangle of Koch after the right atrium has been opened and uses the electrode to trace the anatomic landmarks of the region that are displayed on the computer screen. The position of the electrode is displayed continuously relative to these landmarks and electrograms are recorded at known positions to generate a map. The activation sequences during sinus rhythm, atrioventricular node reentrant tachycardia, "common" and "uncommon" atrial flutter, long RP' tachycardia and retrograde conduction through paranodal pathways are presented. It is concluded that 1) the high spatial resolution reveals physiologically important areas in the maps that are 8 mm long and 3 mm wide and that these areas can be related to specific anatomic landmarks; 2) there are complex electrograms in the region that may reflect the activation of different myocardial layers; and 3) there are marked changes in conduction velocity and direction within the region.

Atrial Flutter↗
PubMed1992

Frequency versus time domain analysis of signal-averaged electrocardiograms. I. Reproducibility of the results.

Three repeated signal-averaged electrocardiographic (ECG) recordings were made in 40 subjects (15 healthy volunteers, 10 patients with ventricular tachycardia without apparent heart disease and 15 patients with ventricular tachycardia after myocardial infarction). In each subject, the three recordings were made within 25 min. The recordings were subsequently analyzed by 1) the conventional time domain method of signal-averaged ECG analysis with use of filter settings of 25 to 250 Hz and 40 to 250 Hz, 2) a spectral analysis method computing the energy area within the spectral boundaries of 40 to 140 Hz and the ratio between the energies of areas within the boundaries 40 to 140 Hz and 0 to 40 Hz, and 3) spectral temporal mapping computing the "normality factor." The study compared the reproducibility of these three approaches to the analysis of signal-averaged ECGs. First, the reproducibility of the diagnostic conclusions (that is, of the diagnosis of late potentials) was compared for the time domain method and for spectral temporal mapping. Second, the reproducibility of the numeric values of individual indexes provided by different methods was compared for all methods by computing the ratios between standard deviations of measurements in individual patients and standard deviation of all measurements. The reproducibility of diagnostic conclusions was significantly higher for the time domain method than for spectral temporal mapping (p less than 0.05, sign test). The numeric reproducibility of the normality factors produced by spectral temporal mapping was significantly lower than the numeric reproducibility of the values of all indexes provided by time domain, spectral area and spectral area ratio methods (p less than 0.05 to 0.00005, Wilcoxon tests). Spectral temporal mapping was the least reproducible method for the analysis of signal-averaged ECGs.

Adult↗